• 1
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277300
  • 2
    Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Endeavor Urol 1999; 54: 5038
  • 3
    Walz J, Burnett AL, Costello AJ et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 2010; 57: 17992
  • 4
    Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 4927
  • 5
    Xylinas E, Durand X, Ploussard G et al. Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer control. Urol Oncol 2011; [Epub ahead of print]
  • 6
    User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 11759
  • 7
    Mooreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 11320
  • 8
    Iacono F, Gianella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 16736
  • 9
    Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 11418
  • 10
    Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 191623
  • 11
    Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 30627
  • 12
    Canguven O, Lagoda G, Sezen SF, Burnett AL. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. J Urol 2009; 181: 281622
  • 13
    Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 2003; 5: 739
  • 14
    Belmadani S, Bernal J, Wei CC et al. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 2007; 171: 77789
  • 15
    Massagua J, Blain SW, Lo RS. TGF beta signalling in growth control, cancer and heritable disorders. Cell 2000; 103: 295309
  • 16
    Rodriguez-Vita J, Sanchez-Lopez E, Esteban V, Ruperez M, Egido J, Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005; 111: 250917
  • 17
    Segal R, Burnett AL. Erectile preservation following radical prostatectomy. Ther Adv Urol 2011; 3: 3546
  • 18
    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 31926
  • 19
    Munding M, Wessells H, Dalkin B. Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urol 2001; 58: 5679
  • 20
    Savoie M, Sandy S, Soloway M. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003; 169: 14624
  • 21
    Fraiman M, McCullough A, Lepor H. Changes in penile morphometrics in men with erectile dysfunction after nerve sparing radical retropubic prostatectomy. Mol Urol 1999; 3: 10915
  • 22
    Gontero P, Galzerano M, Bartoletti R et al. New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. J Urol 2007; 178: 6027
  • 23
    Tobili JE, Stella I, Mazza ON, Ferder L, Inserra F. Candesartan cilexil protects cavernous tissue in spontaneously hypertensive rats. Int J Impot Res 2004; 16: 30512
  • 24
    Baumhäkel M, Custodis F, Schlimmer N, Laufs U, Böhm M. Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan. J Pharmacol Exp Ther 2008; 327: 6928
  • 25
    Yang R, Yang B, Wen Y et al. Losartan, an angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. J Sex Med 2009; 6: 696707
  • 26
    Schlimmer N, Kratz M, Böhm M, Baumhäkel M. Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis. Br J Pharm 2011; 163: 80414
  • 27
    Baumhäkel M, Schlimmer N. Böhm M on behalf of the DO-IT investigators. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res 2008; 20: 493500
  • 28
    Sola S, Mir MQ, Cheema FA et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005; 111: 3438
  • 29
    Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. NEJM 2008; 358: 278795